A yeast-based system to study SARS-CoV-2 Mpro structure and to identify nirmatrelvir resistant mutations
Authors:
Open Access
- 31 August 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 19 (8) , e1011592
Abstract
The SARS-CoV-2 main protease (Mpro) is a major therapeutic target. The Mpro inhibitor, nirmatrelvir, is the antiviral component of Paxlovid, an orally available treatment for COVID-19. As Mpro inhibitor use increases, drug resistant mutations will likely emerge. We have established a non-pathogenic system, in which yeast growth serves as an approximation for Mpro activity, enabling rapid identification of mutants with altered enzymatic activity and drug sensitivity. The E166 residue is known to be a potential hot spot for drug resistance and yeast assays identified substitutions which conferred strong nirmatrelvir resistance and others that compromised activity. On the other hand, N142A and the P132H mutation, carried by the Omicron variant, caused little to no change in drug response and activity. Standard enzymatic assays confirmed the yeast results. In turn, we solved the structures of Mpro E166R, and Mpro E166N, providing insights into how arginine may drive drug resistance while asparagine leads to reduced activity. The work presented here will help characterize novel resistant variants of Mpro that may arise as Mpro antivirals become more widely used.Keywords
Funding Information
- NIH (1R15GM129766-01)
- NIH (AI158775)
- NSF (2200138)
This publication has 48 references indexed in Scilit:
- Glucose Signaling Is Connected to Chromosome Segregation Through Protein Kinase A Phosphorylation of the Dam1 Kinetochore Subunit inSaccharomyces cerevisiaeGenetics, 2018
- Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research2018
- The Perseus computational platform for comprehensive analysis of (prote)omics dataNature Methods, 2016
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Yeast Based Small Molecule Screen for Inhibitors of SARS-CoVPLOS ONE, 2011
- Accessory Mutations Maintain Stability in Drug-Resistant HIV-1 ProteaseJournal of Molecular Biology, 2011
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug DesignJournal of Virology, 2008
- Drug Susceptibilities of Yeast Cells Are Affected by Membrane Lipid CompositionAntimicrobial Agents and Chemotherapy, 2002
- Conservation of substrate specificities among coronavirus main proteasesJournal of General Virology, 2002